Inventor · disambiguated record
Trevor Percival Castor
Also filed as: CASTOR TREVOR · CASTOR TREVOR P · CASTOR TREVOR PERCIVAL
38 granted patents·43 pending applications·942 citations·filing 1992–2024
98Inventor score
Files withAPHIOS CORP36CASTOR TREVOR PERCIVAL29CASTOR TREVOR P8ALEXANDER JONATHAN STEVEN1CASTOR TREVOR1
Top patents by PatentIndex Score
81 records- 0198US8440614B2Polymer microspheres/nanospheres and encapsulating therapeutic proteins thereinCASTOR TREVOR P·Filed 2011·Granted May 14, 2013·112 cites·1 claims
- 0295US7708915B2Polymer microspheres/nanospheres and encapsulating therapeutic proteins thereinCASTOR TREVOR P·Filed 2006·Granted May 4, 2010·22 cites·6 claims
- 0393US5750709AMethod and apparatus for isolating therapeutic compositions from source materialsAPHIOS CORP·Filed 1995·Granted May 12, 1998·62 cites·21 claims
- 0492US5554382AMethods and apparatus for making liposomesAPHIOS CORP·Filed 1993·Granted Sep 10, 1996·133 cites·31 claims
- 0589US5776486AMethods and apparatus for making liposomes containing hydrophobic drugsAPHIOS CORP·Filed 1996·Granted Jul 7, 1998·123 cites·31 claims
- 0689US5440055AMethod and apparatus for extracting taxol from source materialsAPHIOS CORP·Filed 1993·Granted Aug 8, 1995·35 cites·21 claims
- 0788US11639359B2Bryoid compositions, methods of making and use thereofCASTOR TREVOR PERCIVAL·Filed 2021·Granted May 2, 2023·1 cites·3 claims
- 0887US8637074B2Methods for co-encapsulation of combination drugs and co-encapsulated combination drug productCASTOR TREVOR PERCIVAL·Filed 2009·Granted Jan 28, 2014·4 cites·21 claims
- 0986US10954248B2Bryoid compositions, methods of making and use thereofAPHIOS CORP·Filed 2018·Granted Mar 23, 2021·1 cites·3 claims
- 1086US10493030B2Combination HIV therapeuticAPHIOS CORP·Filed 2016·Granted Dec 3, 2019·2 cites·24 claims
- 1186US7147806B2Polymer microspheres/nanospheres and encapsulating therapeutic proteins thereinAPHIOS CORP·Filed 2004·Granted Dec 12, 2006·17 cites·17 claims
- 1284US9034347B2Drug delivery system and method for the treatment of neuro-degenerative diseaseAPHIOS CORP·Filed 2012·Granted May 19, 2015·6 cites·5 claims
- 1382US5877005AViral inactivation method using near critical, supercritical or critical fluidsAPHIOS CORP·Filed 1995·Granted Mar 2, 1999·140 cites·12 claims
- 1482US5380826ASupercritical fluid disruption of and extraction from microbial cellsAPHIOS CORP·Filed 1992·Granted Jan 10, 1995·74 cites·10 claims
- 1581US9994585B2Transplantation therapiesAPHIOS CORP·Filed 2014·Granted Jun 12, 2018·2 cites·16 claims
- 1681US7744935B2Compositions and methods for inhibiting 5-α reductaseCASTOR TREVOR P·Filed 2007·Granted Jun 29, 2010·4 cites·1 claims
- 1781US7033813B2Inactivated vaccines for aids and other infectious diseasesCASTOR TREVOR P·Filed 2002·Granted Apr 25, 2006·12 cites·13 claims
- 1881US2023250107A1Bryoid compositions, methods of making and use thereofCASTOR TREVOR PERCIVAL·Filed 2023·Application pending·0 cites
- 1980US8629177B2Nanoencapsulated delta-9-tetrahydrocannabinolCASTOR TREVOR PERCIVAL·Filed 2011·Granted Jan 14, 2014·7 cites·11 claims
- 2079US8435575B2Use of gingerols for cancer patients suffering from nausea and emesis induced by chemotherapyCASTOR TREVOR·Filed 2010·Granted May 7, 2013·3 cites·9 claims
- 2178US6221153B1Method for producing large crystals of complex moleculesFiled 1998·Granted Apr 24, 2001·65 cites·15 claims
- 2277US8070467B2Polymer microspheres/nanospheres and encapsulating therapeutic proteins thereinCASTOR TREVOR P·Filed 2010·Granted Dec 6, 2011·1 cites·5 claims
- 2377US2024252437A1Methods For and Products From Encapsulation of Drugs in Nanoparticles in a Microgravity EnvironmentAPHIOS CORP·Filed 2024·Application pending·0 cites
- 2472US6569640B1Method of fractionation of biologically-derived materials using critical fluidsAPHIOS CORP·Filed 1998·Granted May 27, 2003·29 cites·8 claims
- 2572US2025346904A1CCR5 and CD4 siRNA-TARGETED PHOSPHOLIPID NANOSOMES THERAPEUTICS FOR TREATMENT OF HIV-1 AND OTHER DISEASESCASTOR TREVOR PERCIVAL·Filed 2024·Application pending·0 cites
- 2669US12071419B2Thermal conversion of CBDA and other carboxylic cannabinoidsCASTOR TREVOR PERCIVAL·Filed 2022·Granted Aug 27, 2024·0 cites·16 claims
- 2768US10723744B2Transplantation therapiesAPHIOS CORP·Filed 2018·Granted Jul 28, 2020·0 cites·17 claims
- 2866US11234932B2Combination HIV therapeuticCASTOR TREVOR PERCIVAL·Filed 2019·Granted Feb 1, 2022·1 cites·15 claims
- 2965US7037534B2Inactivation of viral infections agents by chemiluminescence activated light-sensitive compoundsAPHIOS CORP·Filed 2002·Granted May 2, 2006·3 cites·14 claims
- 3064US2020199146A1Transplantation TherapiesAPHIOS CORP·Filed 2020·Application pending·0 cites
- 3164US2016008377A1Formulations and compositions of vitamin d analogs for treating and preventing cancer and other diseasesAPHIOS CORP·Filed 2014·Application pending·0 cites
- 3264US2022313610A1Methods for and products from encapsulation of drugs in nanoparticles in a microgravity environmentAPHIOS CORP·Filed 2021·Application pending·0 cites
- 3363US2010166806A1Combination therapy comprising the use of protein kinase C modulators and Histone Deacetylase inhibitors for treating HIV-1 latencyAPHIOS CORP·Filed 2008·Application pending·0 cites
- 3462US2020199145A1Transplantation TherapiesAPHIOS CORP·Filed 2020·Application pending·0 cites
- 3561US10258635B2Formulations and compositions of vitamin D analogs for treating and preventing cancer and other diseasesAPHIOS CORP·Filed 2016·Granted Apr 16, 2019·0 cites·4 claims
- 3661US2015291616A1Bryoid compositions, methods of making and use thereofAPHIOS CORP·Filed 2013·Application pending·0 cites
- 3761US2024003872A1Methods for assaying and measuring the efficacy of anti-nausea compoundsCASTOR TREVOR P·Filed 2021·Application pending·0 cites
- 3860US2018272307A1Apparatus and methods for making nanosomes loaded with nucleic acidAPHIOS CORP·Filed 2018·Application pending·0 cites
- 3960US2022010263A1Superfluids disruption of saccharomyces cerevisiae (yeast), cell wall disintegration into nanoparticles and fractionation into beta-glucans, chitin and mannans (mannoproteins)CASTOR TREVOR PERCIVAL·Filed 2021·Application pending·0 cites
- 4059US12337039B2Room temperature stable, single shot mRNA vaccine for COVID-19CASTOR TREVOR PERCIVAL·Filed 2022·Granted Jun 24, 2025·0 cites·7 claims
- 4159US2022111082A1Terminal sterilization of biologicsCASTOR TREVOR PERCIVAL·Filed 2021·Application pending·0 cites
- 4259US2024058435A1Sustained release inactivated vaccinesCASTOR TREVOR PERCIVAL·Filed 2021·Application pending·0 cites
- 4359US2024366818A1Apparatus and method for inactivating viruses and pathogens in human plasma unitsCASTOR TREVOR PERCIVAL·Filed 2021·Application pending·0 cites
- 4459US2022111094A1Pathogen decontamination of personal protective equipment (ppe), face filtering respiratory devices (ffr) and single use medical devices (sud)CASTOR TREVOR PERCIVAL·Filed 2021·Application pending·0 cites
- 4559US2024335575A1Method and apparatus for inactivating pathogens in units of whole blood using superparamagnetic nanoparticles coated with chemiluminescence reagents and broad-spectrum anti-viral therapeuticsCASTOR TREVOR PERCIVAL·Filed 2021·Application pending·0 cites
- 4659US2024350691A1Continuous flow, high throughput apparatus and method for inactivating viruses and pathogens in human plasmaCASTOR TREVOR PERCIVAL·Filed 2021·Application pending·0 cites
- 4759US2024308943A1Extraction, separation and purification of cannabinoids from cannabis staiva and other marijuana biomassCASTOR TREVOR PERCIVAL·Filed 2021·Application pending·0 cites
- 4858US2022203113A1Magnetic nanoparticle plaque clearanceCASTOR TREVOR PERCIVAL·Filed 2021·Application pending·0 cites
- 4958US2022110972A1Apparatus and method for inactivativing viruses and pathogens in convalescent plasma units from recovered covid-19 patientsCASTOR TREVOR PERCIVAL·Filed 2021·Application pending·0 cites
- 5058US2023414697A1Enhanced gingerols for patients suffering from nausea and emesisCASTOR TREVOR PERCIVAL·Filed 2021·Application pending·0 cites
Showing the top 50 of 81 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →